Ona Therapeutics
0 followers
About Ona Therapeutics
Ona Therapeutics is a biotechnology company focused on developing first-in-class antibody-drug conjugates to treat advanced and refractory cancers. Founded in 2019 as a spin-off from ICREA and IRB Barcelona, the company leverages privileged biology to identify novel cancer targets and translate them into antibody therapies, with a lead program targeting a receptor in breast cancer and a monoclonal antibody against CD36. Their research emphasizes precision targeting, efficient development, and collaboration with academic and clinical partners to extend treatment options for patients with limited alternatives. Based in Barcelona, Spain, Ona Therapeutics pursues internal programs and collaborations to advance oncology therapeutics globally.